Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients

BACKGROUND: Nonalcoholic fatty liver disease develops in patients with chronic hepatitis C. Interferon and ribavirin combination therapy is the standard treatment for chronic hepatitis C, but if present, NAFLD can reduce the virological response to anti-HCV therapies. OBJECTIVES: We determined wheth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Malaguarnera, Michele, Vacante, Marco, Russo, Cristina, Gargante, Maria Pia, Giordano, Maria, Bertino, Gaetano, Neri, Sergio, Malaguarnera, Mariano, Galvano, Fabio, Volti, Giovanni Li
Formato: Artigo
Idioma:Inglês
Publicado em: Kowsar 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206670/
https://ncbi.nlm.nih.gov/pubmed/22087124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados